David W. Brighty

621 total citations
23 papers, 529 citations indexed

About

David W. Brighty is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, David W. Brighty has authored 23 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Agronomy and Crop Science and 15 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in David W. Brighty's work include T-cell and Retrovirus Studies (18 papers), Animal Disease Management and Epidemiology (16 papers) and Vector-Borne Animal Diseases (15 papers). David W. Brighty is often cited by papers focused on T-cell and Retrovirus Studies (18 papers), Animal Disease Management and Epidemiology (16 papers) and Vector-Borne Animal Diseases (15 papers). David W. Brighty collaborates with scholars based in United Kingdom, United States and Japan. David W. Brighty's co-authors include Marjorie Rosenberg, Martin Rosenberg, M Ivey-Hoyle, I S Chen, Josefina Piñón Hofbauer, Quentin J. Sattentau, Sandy Y. Welson, Per Johan Klasse, Jonathan Weber and Sharon M. Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

David W. Brighty

23 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Brighty United Kingdom 11 309 218 197 170 148 23 529
Robyn Washington Parks United States 13 627 2.0× 262 1.2× 237 1.2× 176 1.0× 419 2.8× 21 871
Harry Paskalis United States 5 661 2.1× 546 2.5× 499 2.5× 164 1.0× 224 1.5× 5 918
K. Ohishi Japan 9 442 1.4× 375 1.7× 300 1.5× 108 0.6× 46 0.3× 13 592
Pingping Zhou China 13 262 0.8× 208 1.0× 177 0.9× 186 1.1× 309 2.1× 28 830
Kuan-Teh Jeang United States 8 227 0.7× 79 0.4× 76 0.4× 541 3.2× 293 2.0× 8 813
M. WISKERCHEN United States 7 80 0.3× 177 0.8× 80 0.4× 180 1.1× 283 1.9× 9 530
Gisselle N. Medina United States 16 139 0.4× 321 1.5× 232 1.2× 247 1.5× 136 0.9× 40 771
Elizabeth A. Schafer United States 12 131 0.4× 109 0.5× 54 0.3× 132 0.8× 136 0.9× 15 409
Jocelyn Turpin France 12 306 1.0× 170 0.8× 146 0.7× 61 0.4× 148 1.0× 22 441
Michael Wallin Sweden 9 133 0.4× 62 0.3× 47 0.2× 85 0.5× 134 0.9× 11 342

Countries citing papers authored by David W. Brighty

Since Specialization
Citations

This map shows the geographic impact of David W. Brighty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Brighty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Brighty more than expected).

Fields of papers citing papers by David W. Brighty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Brighty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Brighty. The network helps show where David W. Brighty may publish in the future.

Co-authorship network of co-authors of David W. Brighty

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Brighty. A scholar is included among the top collaborators of David W. Brighty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Brighty. David W. Brighty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fox, James M., David W. Brighty, Maria Fernanda Rios Grassi, et al.. (2016). Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo. Viruses. 8(3). 80–80. 9 indexed citations
2.
Nakano, Kazumi, Tomomi Ando, Makoto Yamagishi, et al.. (2013). Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication. Microbes and Infection. 15(6-7). 491–505. 51 indexed citations
3.
4.
Schüttelkopf, Alexander W., et al.. (2011). Charge-Surrounded Pockets and Electrostatic Interactions with Small Ions Modulate the Activity of Retroviral Fusion Proteins. PLoS Pathogens. 7(2). e1001268–e1001268. 16 indexed citations
5.
Brighty, David W., et al.. (2008). Nonhelical Leash and α-Helical Structures Determine the Potency of a Peptide Antagonist of Human T-Cell Leukemia Virus Entry. Journal of Virology. 82(10). 4965–4973. 10 indexed citations
6.
7.
Kelly, Sharon M., et al.. (2008). Basic Residues Are Critical to the Activity of Peptide Inhibitors of Human T Cell Leukemia Virus Type 1 Entry. Journal of Biological Chemistry. 284(10). 6575–6584. 6 indexed citations
8.
Brighty, David W., et al.. (2008). Candidate Polyanionic Microbicides Inhibit Human T-Cell Lymphotropic Virus Type 1 Receptor Interactions, Cell-Free Infection, and Cell-Cell Spread. Antimicrobial Agents and Chemotherapy. 53(2). 678–687. 10 indexed citations
9.
Brighty, David W., et al.. (2007). Resistance to Neutralization by Antibodies Targeting the Coiled Coil of Fusion-active Envelope Is a Common Feature of Retroviruses. Journal of Biological Chemistry. 282(50). 36724–36735. 6 indexed citations
10.
11.
Brighty, David W., et al.. (2005). Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells. Journal of General Virology. 86(5). 1509–1513. 4 indexed citations
12.
Brighty, David W., et al.. (2003). The Human Immunodeficiency Virus LTR-Promoter Region as a Reporter of Stress-Induced Gene Expression. Humana Press eBooks. 99. 277–295. 1 indexed citations
13.
Hofbauer, Josefina Piñón, Per Johan Klasse, Sandy Y. Welson, et al.. (2003). Human T-Cell Leukemia Virus Type 1 Envelope Glycoprotein gp46 Interacts with Cell Surface Heparan Sulfate Proteoglycans. Journal of Virology. 77(18). 9922–9930. 86 indexed citations
14.
Lairmore, Michael D., et al.. (2001). Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells. Virus Research. 78(1-2). 17–34. 22 indexed citations
15.
Brighty, David W., et al.. (2001). Human T-Cell Leukemia Virus Type 1 Receptor Expression among Syncytium-Resistant Cell Lines Revealed by a Novel Surface Glycoprotein-Immunoadhesin. Journal of Virology. 75(17). 8317–8328. 36 indexed citations
16.
Brighty, David W., et al.. (2001). The Synthetic Peptide P-197 Inhibits Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation by a Mechanism That Is Independent of Hsc70. Journal of Virology. 75(21). 10472–10478. 17 indexed citations
17.
Fasken, Milo B., Robert D. C. Saunders, Martin Rosenberg, & David W. Brighty. (2000). A Leptomycin B-sensitive Homologue of Human CRM1 Promotes Nuclear Export of Nuclear Export Sequence-containing Proteins inDrosophila Cells. Journal of Biological Chemistry. 275(3). 1878–1886. 20 indexed citations
18.
Churchill, Melissa J., Janet Moore, Martin Rosenberg, & David W. Brighty. (1996). The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells. Journal of Virology. 70(9). 5786–5790. 10 indexed citations
19.
Brighty, David W. & Marjorie Rosenberg. (1994). A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.. Proceedings of the National Academy of Sciences. 91(18). 8314–8318. 66 indexed citations
20.
Brighty, David W., Martin Rosenberg, I S Chen, & M Ivey-Hoyle. (1991). Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.. Proceedings of the National Academy of Sciences. 88(17). 7802–7805. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robyn Washington Parks Breakdown of academic impact, for papers by Harry Paskalis Breakdown of academic impact, for papers by K. Ohishi Breakdown of academic impact, for papers by Pingping Zhou Breakdown of academic impact, for papers by Kuan-Teh Jeang Breakdown of academic impact, for papers by M. WISKERCHEN Breakdown of academic impact, for papers by Gisselle N. Medina Breakdown of academic impact, for papers by Elizabeth A. Schafer Breakdown of academic impact, for papers by Jocelyn Turpin Breakdown of academic impact, for papers by Michael Wallin
Rankless by CCL
2026